Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Dec;24(e4):e258-63.
doi: 10.1136/tobaccocontrol-2014-051945. Epub 2014 Dec 22.

Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers

Neal L Benowitz  1 , Quan Gan  2 , Maciej L Goniewicz  3 , Wei Lu  2 , Jiying Xu  2 , Xinjian Li  2 , Peyton Jacob 3rd  1 , Stanton Glantz  4
Affiliations
Clinical Trial

Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers

Neal L Benowitz et al. Tob Control. 2015 Dec.

Abstract

Background: Differences in carcinogen exposure from different cigarette products could contribute to differences in smoking-associated cancer incidence among Chinese compared with US smokers.

Methods: Urine concentrations of metabolites of nicotine, the tobacco-specific nitrosamine (TSNA) 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and polycyclic aromatic hydrocarbon metabolites (PAHs) were compared in 238 Chinese and 203 US daily smokers.

Results: Comparing Chinese versus US smokers, daily nicotine intake and nicotine intake per cigarette smoked were found to be similar. When normalised for cigarettes per day, urine NNAL excretion was fourfold higher in US smokers, while the excretion of urine metabolites of the PAHs fluorene, phenanthrene and pyrene metabolites was 50% to fourfold higher in Chinese smokers (all, p<0.0001). Similar results were seen when NNAL and PAHs excretion was normalised for daily nicotine intake.

Conclusions: Patterns of carcinogen exposure differ, with lower exposure to TSNA and higher exposure to PAHs in Chinese compared with US smokers. These results most likely reflect country differences in cigarette tobacco blends and manufacturing processes, as well as different environmental exposures.

Trial registration number: NCT00264342.

Keywords: Carcinogens; Global health; Nicotine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Urine total nicotine equivalents (TNE); (B) TNE/cigarettes per day (CPD) ratio in Chinese compared with US smokers. Data shown as medians and IQ intervals.
Figure 2
Figure 2
(A) Urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol/urine total nicotine equivalents ratio (NNAL/TNE); (B) urine 1-hydroxypyrene (1-HP)/TNE ratio in Chinese compared with US smokers. Data shown as medians and IQ intervals.
See this image and copyright information in PMC

References

    1. Gu D, Kelly TN, Wu X, et al. Mortality attributable to smoking in China. N Engl J Med. 2009;360:150–9. - PubMed
    1. Zhang J, Ou JX, Bai CX. Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology. 2011;16:1165–72. - PubMed
    1. Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368:351–64. - PMC - PubMed
    1. Fujieda M, Yamazaki H, Saito T, et al. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis. 2004;25:2451–8. - PubMed
    1. Liu T, Xie CB, Ma WJ, et al. Association between CYP2A6 genetic polymorphisms and lung cancer: a meta-analysis of case-control studies. Environ Mol Mutagen. 2013;54:133–40. - PubMed

Publication types

Associated data